U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. cobas TaqScreen MPX Test, version 2.0
  1. Vaccines, Blood & Biologics

cobas TaqScreen MPX Test, version 2.0

STN: BL 125459
Proper Name: HIV-1 Group O and M, HIV-2, HCV and /or HBV (HIV-1/HIV-2/HCV/HBV/Multiplex Discriminatory NAT)
Tradename: cobas TaqScreen MPX Test, version 2.0
Manufacturer: Roche Molecular Systems, Inc.
Indication: 

  • cobas TaqScreen MPX Test is aqualitative in vitro test for Human Immunodeficiency Virus Type 1 (HIV-1) Group M RNA, Human Immunodeficiency Virus Type 1 (HIV-1) Group O RNA, Human Immunodeficiency Virus Type 2 (HIV-2) RNA, Hepatitis C Virus (HCV) RNA and Hepatitis B Virus (HBV) DNA in human plasma.

Product Information

Supporting Documents

Back to Top